Nikolaos Perakakis1, Vassilis Mougios2, Ioannis Fatouros3, Aikaterina Siopi2, Dimitrios Draganidis3, Natia Peradze1, Wael Ghaly1,4, Christos S Mantzoros1. 1. Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. 2. School of Physical Education and Sport Science, Aristotle University of Thessaloniki, Thessaloniki, Greece. 3. School of Physical Education and Sport Sciences,University of Thessaly, Karies, Trikala, Greece. 4. Department of Physiology, Fayoum University, Fayoum, Egypt.
Abstract
Context: Clinical trials are evaluating the efficacy of inhibitors of the myostatin pathway in neuromuscular and metabolic diseases. Activins and follistatins are major regulators of the myostatin pathway, but their physiology in relation to metabolic and anthropometric variables and in response to exercise remains to be fully elucidated in humans. Objective: We investigated whether concentrations of circulating activin A, activin B, follistatin, and follistatin-like 3 (FSTL3) are associated with anthropometric and metabolic variables and whether they are affected by exercise. Design: Activin A, activin B, follistatin, and FSTL3 were measured in (1) 80 subjects divided according to age (young vs old) and fitness status (active vs sedentary) before and after exercise at 70% maximal oxygen consumption (VO2max), followed by 90% of VO2max until exhaustion; and (2) 23 subjects [9 healthy and 14 with metabolic syndrome (MetS)] who completed four sessions: no exercise, high-intensity interval exercise, continuous moderate-intensity exercise, and resistance exercise for up to 45 minutes. Results: At baseline, follistatin and FSTL3 concentrations were positively associated with age, fat percentage, and body mass index (P < 0.001). Follistatin was positively associated with serum cholesterol (P = 0.005), low-density lipoprotein cholesterol (P = 0.01), triglycerides (P = 0.033), and blood pressure (P = 0.019), whereas activin A and activin B were higher in physically active participants (P = 0.056 and 0.029, respectively). All exercise types increased the levels of all hormones ∼10% to 21% (P = 0.034 for activin B, P < 0.001 for the others) independent of the presence of MetS. Conclusion: Concentrations of circulating activins and follistatins are associated with metabolic parameters and increase after 45 minutes of exercise.
Context: Clinical trials are evaluating the efficacy of inhibitors of the myostatin pathway in neuromuscular and metabolic diseases. Activins and follistatins are major regulators of the myostatin pathway, but their physiology in relation to metabolic and anthropometric variables and in response to exercise remains to be fully elucidated in humans. Objective: We investigated whether concentrations of circulating activin A, activin B, follistatin, and follistatin-like 3 (FSTL3) are associated with anthropometric and metabolic variables and whether they are affected by exercise. Design: Activin A, activin B, follistatin, and FSTL3 were measured in (1) 80 subjects divided according to age (young vs old) and fitness status (active vs sedentary) before and after exercise at 70% maximal oxygen consumption (VO2max), followed by 90% of VO2max until exhaustion; and (2) 23 subjects [9 healthy and 14 with metabolic syndrome (MetS)] who completed four sessions: no exercise, high-intensity interval exercise, continuous moderate-intensity exercise, and resistance exercise for up to 45 minutes. Results: At baseline, follistatin and FSTL3 concentrations were positively associated with age, fat percentage, and body mass index (P < 0.001). Follistatin was positively associated with serum cholesterol (P = 0.005), low-density lipoprotein cholesterol (P = 0.01), triglycerides (P = 0.033), and blood pressure (P = 0.019), whereas activin A and activin B were higher in physically active participants (P = 0.056 and 0.029, respectively). All exercise types increased the levels of all hormones ∼10% to 21% (P = 0.034 for activin B, P < 0.001 for the others) independent of the presence of MetS. Conclusion: Concentrations of circulating activins and follistatins are associated with metabolic parameters and increase after 45 minutes of exercise.
Authors: Daniil V Popov; Evgeny A Lysenko; Anton V Bachinin; Tatiana F Miller; Nadezda S Kurochkina; Irina V Kravchenko; Vladimir A Furalyov; Olga L Vinogradova Journal: Muscle Nerve Date: 2015-01-06 Impact factor: 3.217
Authors: Arne Yndestad; John Willy Haukeland; Tuva Børresdatter Dahl; Kristian Bjøro; Ivar Prydz Gladhaug; Christ Berge; Jan Kristian Damås; Terese Haaland; Else Marit Løberg; Paul Linnestad; Kåre Birkeland; Zbigniew Konopski; Bente Halvorsen; Rolf Kristian Berge; Pål Aukrust Journal: Am J Gastroenterol Date: 2009-06-16 Impact factor: 10.864
Authors: Katharina Kerschan-Schindl; Markus M Thalmann; Elisabeth Weiss; Maria Tsironi; Ursula Föger-Samwald; Johann Meinhart; Katerina Skenderi; Peter Pietschmann Journal: PLoS One Date: 2015-07-06 Impact factor: 3.240
Authors: Aesha Shah; William C Dodson; Penny M Kris-Etherton; Allen R Kunselman; Christy M Stetter; Carol L Gnatuk; Stephanie J Estes; Kelly C Allison; David B Sarwer; Patrick M Sluss; Christos Coutifaris; Anuja Dokras; Richard S Legro Journal: J Clin Endocrinol Metab Date: 2021-01-01 Impact factor: 5.958